X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2025-04-23 | ABP | Abpro Holdings, Inc. | Suk Jin Wook (Miles) | CEO, COB | P - Purchase | $0.33 | +34,002 | 125,902 | +37% | +$11,113 | |||||
M | 2025-03-18 | ACUT | Accustem Sciences Inc. | Cerrone Gabriele M | Dir, 10% | P - Purchase | $0.51 | +152,802 | 4,872,759 | +3% | +$78,291 | |||||
M | 2025-04-08 | ACUT | Accustem Sciences Inc. | Cerrone Gabriele M | Dir, 10% | P - Purchase | $0.67 | +38,000 | 4,910,759 | +1% | +$25,285 | |||||
M | 2025-04-01 | ADMQ | Adm Endeavors, Inc. | Johnson Marc | CEO | P - Purchase | $0.07 | +232,204 | 60,413,788 | 0% | +$16,732 | |||||
M | 2025-03-31 | ADVM | Adverum Biotechnologies, Inc. | Leonard Braden Michael | 10% | P - Purchase | $4.23 | +34,775 | 5,641,643 | +1% | +$147,076 | |||||
M | 2025-04-22 | ADVM | Adverum Biotechnologies, Inc. | Leonard Braden Michael | 10% | P - Purchase | $3.00 | +350,000 | 3,249,326 | +12% | +$1,048,950 | |||||
2025-04-11 | AIM | Aim Immunotech Inc. | Equels Thomas K | CEO, Pres | P - Purchase | $0.03 | +1,968,504 | 3,867,533 | +104% | +$50,000 | ||||||
2025-04-11 | AIM | Aim Immunotech Inc. | Kellner Ted D | Dir | P - Purchase | $0.03 | +1,968,504 | 3,720,504 | +112% | +$50,000 | ||||||
2025-03-28 | ALUR | Allurion Technologies, Inc. | Gaur Shantanu | CEO | P - Purchase | $3.35 | +8,000 | 70,032 | +13% | +$26,800 | ||||||
2025-04-03 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO | P - Purchase | $1.84 | +5,500 | 347,420 | +2% | +$10,110 | ||||||
2025-04-10 | ARTW | Arts Way Manufacturing Co Inc | Ramsey Randall C. | Dir | P - Purchase | $1.50 | +6,800 | 67,709 | +11% | +$10,200 | ||||||
2025-03-28 | ASPS | Altisource Portfolio Solutions S.A. | Esterman Michelle D. | CFO | P - Purchase | $0.48 | +210,498 | 662,250 | +47% | +$101,039 | ||||||
2025-03-28 | ASPS | Altisource Portfolio Solutions S.A. | Shepro William B | COB, CEO | P - Purchase | $0.48 | +210,498 | 1,339,474 | +19% | +$101,039 | ||||||
D | 2025-04-23 | BCDA | Biocardia, Inc. | Blank Andrew Scott | Dir | P - Purchase | $1.91 | +131,233 | 275,769 | +91% | +$249,999 | |||||
D | 2025-04-23 | BCDA | Biocardia, Inc. | Altman Peter | Pres, CEO | P - Purchase | $1.91 | +26,246 | 138,966 | +23% | +$49,999 | |||||
D | 2025-04-23 | BCDA | Biocardia, Inc. | Stertzer Simon H | Dir | P - Purchase | $1.91 | +104,986 | 243,586 | +76% | +$199,998 | |||||
D | 2025-04-23 | BCDA | Biocardia, Inc. | Facteau Bill | Dir | P - Purchase | $1.91 | +13,123 | 13,123 | New | +$24,999 | |||||
D | 2025-04-23 | BCDA | Biocardia, Inc. | McClung David | CFO | P - Purchase | $1.91 | +13,123 | 43,131 | +44% | +$24,999 | |||||
M | 2025-04-09 | BDCO | Blue Dolphin Energy Co | Carroll Jonathan P | CEO, Pres, 10% | P - Purchase | $1.86 | +6,000 | 4,120,779 | 0% | +$11,130 | |||||
M | 2025-04-04 | BDCO | Blue Dolphin Energy Co | Carroll Jonathan P | CEO, Pres, 10% | P - Purchase | $2.05 | +45,000 | 4,114,779 | +1% | +$92,363 | |||||
M | 2025-04-16 | BLNE | Beeline Holdings, Inc. | Freedman Joseph David | Dir | P - Purchase | $1.17 | +20,000 | 105,910 | +23% | +$23,330 | |||||
2025-04-16 | BLNE | Beeline Holdings, Inc. | Liuzza Nicholas Reyland Jr | CEO, 10% | P - Purchase | $1.16 | +18,000 | 1,898,522 | +1% | +$20,849 | ||||||
M | 2025-04-16 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.29 | +7,874 | 4,164,300 | 0% | +$25,906 | |||||
2025-03-31 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.32 | +106,000 | 4,033,547 | +3% | +$351,920 | ||||||
AM | 2025-03-13 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.25 | +856,609 | 3,927,547 | +28% | +$2,784,419 | |||||
M | 2025-04-03 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.19 | +74,440 | 4,107,987 | +2% | +$237,406 | |||||
2025-04-21 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.27 | +8,801 | 4,173,101 | 0% | +$28,782 | ||||||
M | 2025-04-08 | BTMD | Biote Corp. | Guines LLC | 10% | P - Purchase | $3.21 | +48,439 | 4,156,426 | +1% | +$155,388 | |||||
M | 2025-04-04 | BUKS | Butler National Corp | Daly Joseph Patrick | Dir, 10% | P - Purchase | $1.50 | +70,000 | 8,677,886 | +1% | +$105,266 | |||||
M | 2025-04-08 | BUKS | Butler National Corp | Daly Joseph Patrick | Dir, 10% | P - Purchase | $1.44 | +7,500 | 8,685,386 | 0% | +$10,799 | |||||
M | 2025-04-08 | BUKS | Butler National Corp | Daly Joseph Patrick | Dir, 10% | P - Purchase | $1.45 | +12,500 | 8,697,886 | 0% | +$18,075 | |||||
2025-03-31 | CATX | Perspective Therapeutics, Inc. | Woods Lori A | Dir | P - Purchase | $2.13 | +23,475 | 188,267 | +14% | +$49,999 | ||||||
M | 2025-03-28 | CATX | Perspective Therapeutics, Inc. | Williamson Robert F III | Dir | P - Purchase | $2.19 | +60,337 | 109,348 | +123% | +$132,151 | |||||
2025-03-28 | CATX | Perspective Therapeutics, Inc. | Graham Juan | CFO | P - Purchase | $2.25 | +33,333 | 35,354 | >999% | +$74,946 | ||||||
2025-03-28 | CATX | Perspective Therapeutics, Inc. | Spoor Johan M. | CEO | P - Purchase | $2.24 | +26,676 | 87,683 | +44% | +$59,673 | ||||||
M | 2025-04-10 | CCO | Clear Channel Outdoor Holdings, Inc. | Moreno Arturo R | 10% | P - Purchase | $1.01 | +386,449 | 59,729,814 | +1% | +$390,702 | |||||
2025-04-14 | CCO | Clear Channel Outdoor Holdings, Inc. | Moreno Arturo R | 10% | P - Purchase | $1.01 | +500,000 | 60,229,814 | +1% | +$505,000 | ||||||
M | 2025-04-21 | CCO | Clear Channel Outdoor Holdings, Inc. | Moreno Arturo R | 10% | P - Purchase | $0.96 | +83,221 | 61,499,128 | 0% | +$79,846 | |||||
M | 2025-04-04 | CCO | Clear Channel Outdoor Holdings, Inc. | Moreno Arturo R | 10% | P - Purchase | $0.96 | +5,000,000 | 57,432,534 | +10% | +$4,775,000 | |||||
M | 2025-04-16 | CCO | Clear Channel Outdoor Holdings, Inc. | Moreno Arturo R | 10% | P - Purchase | $0.93 | +1,186,093 | 61,415,907 | +2% | +$1,107,175 | |||||
M | 2025-04-08 | CCO | Clear Channel Outdoor Holdings, Inc. | Moreno Arturo R | 10% | P - Purchase | $0.90 | +1,910,831 | 59,343,365 | +3% | +$1,727,423 | |||||
M | 2025-04-01 | CDXS | Codexis, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $2.36 | +115,000 | 9,615,000 | +1% | +$271,788 | |||||
M | 2025-04-15 | CDXS | Codexis, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $2.13 | +140,000 | 9,855,000 | +1% | +$298,773 | |||||
2025-04-08 | CDXS | Codexis, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $1.98 | +100,000 | 9,715,000 | +1% | +$198,380 | ||||||
2025-04-07 | CIA | Citizens, Inc. | Stenberg Jon | Pres, CEO | P - Purchase | $3.89 | +106,340 | 263,379 | +68% | +$413,250 | ||||||
2025-04-08 | CIA | Citizens, Inc. | Stenberg Jon | Pres, CEO | P - Purchase | $4.20 | +10,000 | 273,379 | +4% | +$42,000 | ||||||
2025-03-27 | CJMB | Callan Jmb Inc. | Croyle David J | Chief Medical Officer, 10% | P - Purchase | $4.50 | +25,000 | 775,000 | +3% | +$112,500 | ||||||
2025-04-07 | CMPX | Compass Therapeutics, Inc. | Lerner Neil | CHIEF ACCOUNTING OFFICER | P - Purchase | $1.42 | +20,000 | 320,000 | +7% | +$28,400 | ||||||
2025-04-07 | CMPX | Compass Therapeutics, Inc. | Anderman Jonathan | GC, Corporate Sec | P - Purchase | $1.54 | +20,000 | 21,000 | >999% | +$30,800 | ||||||
2025-04-10 | CNFR | Conifer Holdings, Inc. | Smith James Grant | Dir | P - Purchase | $0.67 | +20,150 | 36,150 | +126% | +$13,501 | ||||||
2025-04-07 | CNFR | Conifer Holdings, Inc. | Sarafa Joseph D | Dir | P - Purchase | $0.53 | +100,000 | 350,000 | +40% | +$53,000 | ||||||
2025-04-07 | CNFR | Conifer Holdings, Inc. | Meloche Harold J | CFO, Treasurer | P - Purchase | $0.52 | +22,000 | 72,588 | +43% | +$11,458 | ||||||
2025-04-09 | CNFR | Conifer Holdings, Inc. | Smith James Grant | Dir | P - Purchase | $0.68 | +16,000 | 16,000 | New | +$10,880 | ||||||
2025-04-22 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.36 | +175,000 | 4,945,214 | +4% | +$63,000 | ||||||
2025-04-21 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.32 | +654,912 | 4,770,214 | +16% | +$208,000 | ||||||
2025-04-24 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.40 | +177,234 | 5,327,448 | +3% | +$71,000 | ||||||
2025-04-23 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.40 | +205,000 | 5,150,214 | +4% | +$82,000 | ||||||
M | 2025-04-02 | DC | Dakota Gold Corp. | Quartermain Robert | Pres, CEO | P - Purchase | $2.58 | +65,000 | 0 | -100% | +$168,000 | |||||
M | 2025-04-04 | DHF | Bny Mellon High Yield Strategies Fund | Dimartino Joseph S | Dir | P - Purchase | $2.35 | +20,000 | 220,000 | +10% | +$46,971 | |||||
2025-04-11 | DLTH | Duluth Holdings Inc. | Agrawal Heena | SVP, CFO | P - Purchase | $1.84 | +9,000 | 225,093 | +4% | +$16,560 | ||||||
2025-04-03 | DLTH | Duluth Holdings Inc. | Paschke Brett Lee | Dir | P - Purchase | $1.81 | +50,000 | 112,760 | +80% | +$90,500 | ||||||
2025-04-17 | DYNR | Dynaresource, Inc. | Rose Matthew K | Dir, 10% | P - Purchase | $1.00 | +200,000 | 4,966,894 | +4% | +$200,000 | ||||||
2025-04-09 | EARN | Ellington Credit Co | Borenstein Gregory Morris | Portfolio Manager | P - Purchase | $4.73 | +8,000 | 18,000 | +80% | +$37,874 | ||||||
2025-04-02 | ERNA | Eterna Therapeutics Inc. | Cherington Charles | 10% | P - Purchase | $0.10 | +3,768,397 | 20,401,602 | +23% | +$394,174 | ||||||
2025-04-03 | EU | Encore Energy Corp. | Sheriff William M | Exec COB | P - Purchase | $1.21 | +50,000 | 2,357,931 | +2% | +$60,500 | ||||||
2025-04-03 | FF | Futurefuel Corp. | Bedell Donald C. | Dir | P - Purchase | $4.00 | +10,000 | 109,975 | +10% | +$40,000 | ||||||
2025-04-03 | FF | Futurefuel Corp. | Rowe Richard P. | Dir | P - Purchase | $3.95 | +15,000 | 20,000 | +300% | +$59,250 | ||||||
2025-04-01 | FTCI | Ftc Solar, Inc. | Chatila Ahmad R | Dir | P - Purchase | $2.91 | +16,922 | 1,967,968 | +1% | +$49,243 | ||||||
2025-04-02 | FTCI | Ftc Solar, Inc. | Chatila Ahmad R | Dir | P - Purchase | $2.93 | +16,740 | 1,984,708 | +1% | +$49,048 | ||||||
2025-03-28 | FTEK | Fuel Tech, Inc. | Arnone Vincent J | Pres, CEO | P - Purchase | $1.05 | +15,000 | 485,879 | +3% | +$15,750 | ||||||
M | 2025-03-27 | GDRZF | Gold Reserve Ltd | Camac Capital, LLC | 10% | P - Purchase | $1.77 | +37,000 | 20,142,283 | 0% | +$65,600 | |||||
M | 2025-04-03 | GDRZF | Gold Reserve Ltd | Camac Capital, LLC | 10% | P - Purchase | $1.67 | +32,475 | 20,174,758 | 0% | +$54,321 | |||||
2025-04-15 | GMGI | Golden Matrix Group, Inc. | Milovanovic Aleksandar | Member of 10% Reporting Group, 10% | P - Purchase | $1.95 | +146,080 | 84,608,663 | 0% | +$284,856 | ||||||
M | 2025-04-10 | GMGI | Golden Matrix Group, Inc. | Milovanovic Aleksandar | Member of 10% Reporting Group, 10% | P - Purchase | $1.94 | +150,880 | 84,462,583 | 0% | +$292,515 | |||||
M | 2025-03-31 | GMGI | Golden Matrix Group, Inc. | Milovanovic Aleksandar | Member of 10% Reporting Group, 10% | P - Purchase | $2.06 | +7,586 | 79,467,877 | 0% | +$15,596 | |||||
2025-04-01 | GOVX | Geovax Labs, Inc. | Dodd David A | Pres, CEO | P - Purchase | $1.08 | +10,000 | 36,661 | +38% | +$10,800 | ||||||
AM | 2025-04-23 | GREE | Greenidge Generation Holdings Inc. | Krug Christopher J. | Dir | P - Purchase | $0.83 | +125,000 | 276,607 | +82% | +$103,916 | |||||
M | 2025-04-23 | GREE | Greenidge Generation Holdings Inc. | Krug Christopher J. | Dir | P - Purchase | $0.83 | +125,000 | 276,607 | +82% | +$103,916 | |||||
M | 2025-04-10 | GTE | Gran Tierra Energy Inc. | Equinox Partners Investment Management LLC | 10% | P - Purchase | $3.84 | +83,531 | 4,411,851 | +2% | +$320,571 | |||||
M | 2025-04-02 | GTE | Gran Tierra Energy Inc. | Equinox Partners Investment Management LLC | 10% | P - Purchase | $4.82 | +117,000 | 3,833,114 | +3% | +$563,400 | |||||
M | 2025-04-14 | GTE | Gran Tierra Energy Inc. | Equinox Partners Investment Management LLC | 10% | P - Purchase | $4.23 | +58,609 | 4,470,460 | +1% | +$248,063 | |||||
M | 2025-04-04 | GTE | Gran Tierra Energy Inc. | Equinox Partners Investment Management LLC | 10% | P - Purchase | $4.02 | +269,460 | 4,102,574 | +7% | +$1,082,582 | |||||
2025-04-21 | GTE | Gran Tierra Energy Inc. | Equinox Partners Investment Management LLC | 10% | P - Purchase | $4.66 | +98,678 | 4,759,296 | +2% | +$459,839 | ||||||
M | 2025-04-16 | GTE | Gran Tierra Energy Inc. | Equinox Partners Investment Management LLC | 10% | P - Purchase | $4.79 | +190,158 | 4,660,618 | +4% | +$910,525 | |||||
2025-04-08 | GTE | Gran Tierra Energy Inc. | Equinox Partners Investment Management LLC | 10% | P - Purchase | $3.81 | +225,746 | 4,328,320 | +6% | +$860,092 | ||||||
2025-04-22 | GTEC | Greenland Technologies Holding Corp. | Wang Peter | Dir, 10% | P - Purchase | $1.00 | +6,211,740 | 6,214,240 | >999% | +$6,211,740 | ||||||
DM | 2025-03-07 | GTHP | Guided Therapeutics Inc | Imhoff John E | Dir, 10% | P - Purchase | $0.10 | +1,263,355 | 17,992,380 | +8% | +$126,307 | |||||
D | 2025-03-18 | GTHP | Guided Therapeutics Inc | James Michael C | Dir | P - Purchase | $0.10 | +412,945 | 525,717 | +366% | +$41,295 | |||||
2025-04-10 | HUMA | Humacyte, Inc. | Parikh Shamik J | Chief Medical Officer | P - Purchase | $1.55 | +7,500 | 7,500 | New | +$11,625 | ||||||
2025-04-10 | HUMA | Humacyte, Inc. | Sander Dale A. | CFO, Chief Corp. Deve. Officer | P - Purchase | $1.53 | +20,000 | 42,600 | +88% | +$30,600 | ||||||
2025-04-07 | HUMA | Humacyte, Inc. | Constantino Michael T. | Dir | P - Purchase | $1.26 | +16,000 | 32,950 | +94% | +$20,160 | ||||||
2025-04-08 | HUMA | Humacyte, Inc. | Sebelius Kathleen | Dir | P - Purchase | $1.32 | +50,000 | 91,207 | +121% | +$66,000 | ||||||
D | 2025-03-18 | IMG | Cimg Inc. | Yy Tech Inc | 10% | P - Purchase | $0.52 | +3,074,590 | 7,125,872 | +76% | +$1,598,787 | |||||
D | 2025-03-18 | IMG | Cimg Inc. | Joyer Investment Ltd. | 10% | P - Purchase | $0.52 | +3,074,590 | 7,125,872 | +76% | +$1,598,787 | |||||
D | 2025-03-18 | IMG | Cimg Inc. | Dada Business Trading Co., Ltd. | 10% | P - Purchase | $0.52 | +2,529,236 | 6,739,761 | +60% | +$1,315,203 | |||||
D | 2025-03-18 | IMG | Cimg Inc. | Vmade Co., Ltd | 10% | P - Purchase | $0.52 | +2,937,787 | 7,400,282 | +66% | +$1,527,649 | |||||
2025-04-24 | IRIX | Iridex Corp | Shuda Scott | Dir | P - Purchase | $1.20 | +21,457 | 129,523 | +20% | +$25,748 | ||||||
M | 2025-04-21 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $1.07 | +20,000 | 200,476 | +11% | +$21,371 | |||||
2025-04-23 | IRIX | Iridex Corp | Huss Beverly A | Dir | P - Purchase | $1.22 | +25,900 | 92,639 | +39% | +$31,500 | ||||||
2025-03-28 | ISPO | Inspirato Inc | Zamani Payam | CEO, 10% | P - Purchase | $4.57 | +29,500 | 1,140,000 | +3% | +$134,815 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |